Fetal biometry following in-utero exposure to dolutegravir-based or efavirenz-based antiretroviral therapy

被引：2
|
作者：
Banda, Francis M. [1 ]
Powis, Kathleen M. [2 ,3 ,4 ,5 ]
Sun, Shan [6 ]
Makhema, Joseph [2 ]
Masasa, Gosego [2 ]
Yee, Lynn M. [7 ]
Jao, Jennifer [2 ,8 ,9 ]
机构：
[1] Univ Botswana, Dept Paediat & Adolescent Hlth, Fac Med, P Bag 00713, Gaborone, Botswana
[2] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[3] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA
[6] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Chicago, IL 60611 USA
[7] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA
[8] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[9] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
AIDS | 2020年 / 34卷 / 15期
关键词：
D O I：
10.1097/QAD.0000000000002674
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2336 / 2337
页数：2
相关论文
共 50 条
  • [1] Neurodevelopmental outcomes in children exposed in utero to dolutegravir- or efavirenz-based antiretroviral treatment
    Cassidy, Adam R.
    Mayondi, Gloria
    Williams, Paige L.
    Moabi, Kebaiphe
    Lemahieu, Allison
    Kamanga, Naledi
    Powis, Kathleen M.
    Isquith, Peter
    Ramaabya, Dinah
    Banda, Francis M.
    Makhema, Joseph
    Kammerer, Betsy
    Lockman, Shahin
    AIDS, 2025, 39 (05) : 609 - 617
  • [2] Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo
    Bisio, Francesca
    Nicco, Elena
    Calzi, Anna
    Giacobbei, Daniele Roberto
    Mesinil, Alessio
    Banguissa, Hubert
    Vividila, Nicole Edith
    Mahoungou, Pelagie
    Boumba, Jean Denis
    Mboungou, Franc Astyanax Mayinda
    Bruzzone, Bianca
    Ratto, Sandra
    Icardi, Giancarlo
    Viscoli, Claudio
    Bruzzi, Paolo
    NEW MICROBIOLOGICA, 2015, 38 (02): : 185 - 192
  • [3] Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
    Zash, Rebecca
    Jacobson, Denise L.
    Diseko, Modiegi
    Mayondi, Gloria
    Mmalane, Mompati
    Essex, Max
    Gaolethe, Tendani
    Petlo, Chipo
    Lockman, Shahin
    Holmes, Lewis B.
    Makhema, Joseph
    Shapiro, Roger L.
    LANCET GLOBAL HEALTH, 2018, 6 (07): : E804 - E810
  • [4] Neuropsychiatric adverse drug reactions and associated factors in a cohort of individuals starting dolutegravir-based or efavirenz-based antiretroviral therapy in Belo Horizonte, Brazil
    Mendes, Jullye Campos
    Braga, Maria das Gracas
    Reis, Adriano Max Moreira
    Silveira, Micheline Rosa
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 523 - 531
  • [5] Hyperglycemia After Dolutegravir-Based Antiretroviral Therapy
    Hailu, Workagegnehu
    Tesfaye, Tsebaot
    Tadesse, Abilo
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 503 - 507
  • [6] Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1
    Ayouba, A.
    Butel, C.
    Cournil, A.
    Delaporte, E.
    Eymard-Duvernay, S.
    Granouillac, B.
    Izard, S.
    Lacroix, A.
    Leroy, S.
    Peeters, M.
    Perrineau, S.
    Serrano, L.
    Reynes, J.
    Tovar-Sanchez, T.
    Vidal, N.
    Fouda, P. J.
    Kounfack, C.
    Mougnoutou, R.
    Olinga, J.
    Omgba, V.
    Ngande, S. C. Tchokonte
    Ymele, B.
    Mpacko, C. D. Epoupa
    Mpoudi-Etame, M.
    Fotso, M.
    Moukoko, R.
    Nke, T.
    Akamba, A.
    Bassega, P. Omgba
    Fotack, S. B. Tongo
    Ngono, S.
    Tanga, M.
    Aghokeng, A.
    Ebong, E.
    Mbesse, G. Edoul
    Tsongo, M.
    Mpoudi-Ngole, E.
    Abong, T.
    Ciaffi, L.
    Koulla-Shiro, S.
    Legac, S.
    Lem, S.
    Manirakiza, G.
    Tata, D. Tetsa
    Varloteaux, M.
    Boyer, S.
    Bousmah, M.
    Maradan, G.
    Nishimwe, M. L.
    Spire, B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (09): : 816 - 826
  • [7] In utero and Lactation Exposure to Dolutegravir-based Combination Antiretroviral Therapy Reduced Trabecular Bone but not Cortical Bone Mass in Rats
    Sridhar, Abhayavarshini
    Harry, Jean
    Cunny, Helen
    Ross, Ryan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 255 - 255
  • [8] Comparing the efficacy and safety of dolutegravir and efavirenz-based antiretroviral regimens: A retrospective study
    Oreagba, Ibrahim Adekunle
    Adedeji, Olumuyiwa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 472 - 472
  • [9] Cognitive performance, neuropsychiatric symptoms, and cerebrospinal fluid viral control following programmatic switch from efavirenz-based to dolutegravir-based antiretroviral therapy in South Africa (CONNECT) a prospective cohort study
    Nightingale, Sam
    Dreyer, Anna J.
    Thomas, Kevin G. F.
    van Zyl, Gert
    Decloedt, Eric
    Naude, Petrus J. W.
    Orrell, Catherine
    Sinxadi, Phumla
    Winston, Alan
    Khoo, Saye
    Joska, John A.
    LANCET HIV, 2024, 11 (10): : e680 - e689
  • [10] Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
    Adelline Twimukye
    Miriam Laker
    Eva Agnes Laker Odongpiny
    Florence Ajok
    Henry Onen
    Ivan Kalule
    Phoebe Kajubi
    Kay Seden
    Noela Owarwo
    Agnes Kiragga
    Mari Armstrong-Hough
    Anne Katahoire
    Andrew Mujugira
    Mohammed Lamorde
    Barbara Castelnuovo
    BMC Infectious Diseases, 21
12345